摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-isopropyloxy-1-methyl-4-nitrobenzene | 136187-51-4

中文名称
——
中文别名
——
英文名称
2-isopropyloxy-1-methyl-4-nitrobenzene
英文别名
1-(1-methylethoxy)-2-methyl-5-nitrobenzene;1-methyl-4-nitro-2-propan-2-yloxybenzene
2-isopropyloxy-1-methyl-4-nitrobenzene化学式
CAS
136187-51-4
化学式
C10H13NO3
mdl
——
分子量
195.218
InChiKey
VHKVJWYWXIAHJU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    55
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-isopropyloxy-1-methyl-4-nitrobenzeneN-溴代丁二酰亚胺(NBS)偶氮二异丁腈 作用下, 以 四氯化碳 为溶剂, 以89%的产率得到
    参考文献:
    名称:
    单芳基酰胺类抗疟药的合成及药理评价
    摘要:
    含有两个吡啶基酰胺基末端基团(bis-AIA)的丙烯酰胺(AIA)化合物具有出色的体外抗霉菌活性,领先的bis-AIA DB766(2,5-bis [2-(2-异丙氧基)-4-(2-吡啶基)吡啶)氨基苯基]呋喃)口服时在内脏利什曼病模型中很活跃。合成了18个包含一个吡啶基酰亚胺酰胺单端基团(mono-AIA)的化合物,并评估了其抗疟药的潜力。这些化合物中的六个对细胞内利什曼原虫和亚马逊利什曼原虫均表现出亚微摩尔效价与J774巨噬细胞细胞系相比,这些化合物中的三种对寄生虫的选择性指数也达到25或更高。当以100 mg / kg / day的剂量口服5天时,化合物1b(N-(3-异丙氧基-4-(5-苯基呋喃-2-基)苯基)吡啶甲酰亚胺酰胺甲磺酸盐)可降低46%的肝寄生虫病。L. donovani感染的小鼠。因此,单-AIA是用于抗衰老药物开发的一类新的候选分子。
    DOI:
    10.1016/j.bmcl.2016.03.082
  • 作为产物:
    描述:
    5-硝基-2-甲基苯酚2-溴丙烷sodium hydroxide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 2.5h, 以92%的产率得到2-isopropyloxy-1-methyl-4-nitrobenzene
    参考文献:
    名称:
    Design and synthesis of 7-alkoxy-4-heteroarylamino-3-quinolinecarbonitriles as dual inhibitors of c-Src kinase and nitric oxide synthase
    摘要:
    Because both c-Src and iNOS are key regulatory enzymes in tumorigenesis, a new series of 4-heteroarylamino-3-quinolinecarbonitriles as potent dual inhibitors of both enzymes were designed, prepared, and evaluated for blocking multiple signaling pathways in cancer therapy. All compounds were evaluated by two related enzyme inhibition assays and an anti-proliferation assay in vitro. The results showed that most compounds could inhibit both enzymes, and several of them showed potent inhibition activity against different cancer cell lines. The best compound 20 (CPU-Y020) showed the IC(50) values of 6.58 and 7.61 mu M toward colon cancer HT-29 and liver cancer HepG2 cell lines. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2008.04.065
点击查看最新优质反应信息

文献信息

  • Pesticidal 3-arylpyrimidinyl ethers and thioethers
    申请人:Uniroyal Chemical Company, Inc.
    公开号:US05134144A1
    公开(公告)日:1992-07-28
    This invention is related to a novel class of 3-arylpyrimidine ethers and thioethers having insecticidal, miticidal and nematocidal activity at low concentration. The class of compounds is represented by formula (I): ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, X and Y have the significance given in the description. Pesticidal compositions, methods of controlling pests and methods for preparing the compounds are within the scope of the invention.
    这项发明涉及一种新型的3-芳基嘧啶醚和硫醚类化合物,具有在低浓度下对昆虫、螨虫和线虫的杀虫、杀螨和杀线虫活性。该类化合物由式(I)所代表:##STR1## 其中R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.5、R.sup.6、R.sup.7、X和Y在描述中具有所给定的含义。杀虫剂组合物、控制害虫的方法以及制备这些化合物的方法均属于该发明的范围。
  • US5134144A
    申请人:——
    公开号:US5134144A
    公开(公告)日:1992-07-28
  • [EN] PESTICIDAL 3-ARYLURACIL ETHERS AND THIOETHERS
    申请人:UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE
    公开号:WO1991007393A1
    公开(公告)日:1991-05-30
    (EN) This invention is related to a novel class of 3-arylpyrimidine ethers and thioethers having insecticidal, miticidal and nematocidal activity at low concentration. The class of compounds is represented by formula (I), wherein R1, R2, R3, R4, R5, R6, R7, X and Y have the significance given in the description. Pesticidal compositions, methods of controlling pests and methods for preparing the compounds are within the scope of the invention.(FR) Une nouvelle classe d'éthers et de thiotéthers de 3-arylpyrimidine a des propriétés insecticides, miticides et nématocides à de faibles concentrations. Cette nouvelle classe de composés est représentée par la formule (I), dans laquelle R1, R2, R3, R4, R5, R6, R7, X et Y ont la signification donnée dans la description. L'invention concerne des compositions pesticides, des procédés d'élimination de parasites et des procédés de préparation de ces composés.
  • Design and synthesis of 7-alkoxy-4-heteroarylamino-3-quinolinecarbonitriles as dual inhibitors of c-Src kinase and nitric oxide synthase
    作者:Xin Cao、Qi-Dong You、Zhi-Yu Li、Qing-Long Guo、Jing Shang、Ming Yan、Ji-Wang Chern、Men-Ling Chen
    DOI:10.1016/j.bmc.2008.04.065
    日期:2008.6
    Because both c-Src and iNOS are key regulatory enzymes in tumorigenesis, a new series of 4-heteroarylamino-3-quinolinecarbonitriles as potent dual inhibitors of both enzymes were designed, prepared, and evaluated for blocking multiple signaling pathways in cancer therapy. All compounds were evaluated by two related enzyme inhibition assays and an anti-proliferation assay in vitro. The results showed that most compounds could inhibit both enzymes, and several of them showed potent inhibition activity against different cancer cell lines. The best compound 20 (CPU-Y020) showed the IC(50) values of 6.58 and 7.61 mu M toward colon cancer HT-29 and liver cancer HepG2 cell lines. (C) 2008 Elsevier Ltd. All rights reserved.
  • Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents
    作者:Xiaohua Zhu、Abdelbasset A. Farahat、Meena Mattamana、April Joice、Trupti Pandharkar、Elizabeth Holt、Moloy Banerjee、Jamie L. Gragg、Laixing Hu、Arvind Kumar、Sihyung Yang、Michael Zhuo Wang、David W. Boykin、Karl A. Werbovetz
    DOI:10.1016/j.bmcl.2016.03.082
    日期:2016.5
    (bis-AIAs) possess outstanding in vitro antileishmanial activity, and the frontrunner bis-AIA DB766 (2,5-bis[2-(2-isopropoxy)-4-(2-pyridylimino)aminophenyl]furan) is active in visceral leishmaniasis models when given orally. Eighteen compounds containing a single pyridylimidamide terminal group (mono-AIAs) were synthesized and evaluated for their antileishmanial potential. Six of these compounds exhibited
    含有两个吡啶基酰胺基末端基团(bis-AIA)的丙烯酰胺(AIA)化合物具有出色的体外抗霉菌活性,领先的bis-AIA DB766(2,5-bis [2-(2-异丙氧基)-4-(2-吡啶基)吡啶)氨基苯基]呋喃)口服时在内脏利什曼病模型中很活跃。合成了18个包含一个吡啶基酰亚胺酰胺单端基团(mono-AIA)的化合物,并评估了其抗疟药的潜力。这些化合物中的六个对细胞内利什曼原虫和亚马逊利什曼原虫均表现出亚微摩尔效价与J774巨噬细胞细胞系相比,这些化合物中的三种对寄生虫的选择性指数也达到25或更高。当以100 mg / kg / day的剂量口服5天时,化合物1b(N-(3-异丙氧基-4-(5-苯基呋喃-2-基)苯基)吡啶甲酰亚胺酰胺甲磺酸盐)可降低46%的肝寄生虫病。L. donovani感染的小鼠。因此,单-AIA是用于抗衰老药物开发的一类新的候选分子。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐